Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
Saved in:
| Title: | Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers. |
|---|---|
| Authors: | Kreuter, Alexander1 (AUTHOR), Rasokat, Heinrich2 (AUTHOR), Klouche, Mariam3 (AUTHOR), Esser, Stefan4 (AUTHOR), Bader, Armin1 (AUTHOR), Gambichler, Thilo5 (AUTHOR), Altmeyer, Peter1 (AUTHOR), Brockmeyer, Norbert H.1 (AUTHOR) |
| Source: | Cancer Investigation. 2005, Vol. 23 Issue 8, p653-659. 7p. 2 Color Photographs, 2 Diagrams, 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
